2-201258367-G-C
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_001080125.2(CASP8):āc.136G>Cā(p.Gly46Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,613,900 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Consequence
NM_001080125.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CASP8 | NM_001080125.2 | c.136G>C | p.Gly46Arg | missense_variant | 1/9 | NP_001073594.1 | ||
CASP8 | NM_001400642.1 | c.136G>C | p.Gly46Arg | missense_variant | 1/8 | NP_001387571.1 | ||
CASP8 | NM_001400665.1 | c.136G>C | p.Gly46Arg | missense_variant | 1/6 | NP_001387594.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CASP8 | ENST00000358485.8 | c.136G>C | p.Gly46Arg | missense_variant | 1/9 | 1 | ENSP00000351273.4 | |||
CASP8 | ENST00000264275.9 | c.-26-8094G>C | intron_variant | 1 | ENSP00000264275.5 | |||||
CASP8 | ENST00000392258.7 | c.-26-8094G>C | intron_variant | 1 | ENSP00000376087.3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152182Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000808 AC: 2AN: 247654Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134552
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461718Hom.: 0 Cov.: 34 AF XY: 0.00000413 AC XY: 3AN XY: 727168
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152182Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74332
ClinVar
Submissions by phenotype
Autoimmune lymphoproliferative syndrome type 2B Benign:1
Likely benign, no assertion criteria provided | clinical testing | UOSD Laboratory of Genetics & Genomics of Rare Diseases, Istituto Giannina Gaslini | May 21, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at